Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation among others, is a vasodilator that is used for the treatment of pulmonary arterial hypertension.
The analysis highlights Applications, Research and Art as prominent areas in the source structure around Treprostinil.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Treprostinil shows recurring relationship patterns in the source. For example, Treprostinil → Cost-minimization, Current Medical Research, December, Desjardins, Hague LK, Narine, Opinion, PMID, S2CID, Schilz, Vicente, Walker JH Another extracted example is Treprostinil → Clinical, ClinicalTrials, Dry Powder Inhalation, INSPIRE, Investigation, MedlinePlus, MedlinePlus Drug Information, NCT03399604, Pharmacology, Safety, Treprostinil Oral Inhalation. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
inhalation medical use pulmonary hypertension approved united states treatment may medlineplus remodulin tyvaso arterial orenitram powder oral indicated vasodilator drug
TTTA extracted 63 structured relationships around Treprostinil. Examples in this analysis include Treprostinil → AHFS/Drugs.com → Monograph and Treprostinil → ATC code → B01AC21 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Treprostinil | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Treprostinil | ATC code | B01AC21 (WHO) | 1.00 | infobox |
| Treprostinil | Bioavailability | ~100% | 1.00 | infobox |
| Treprostinil | CAS Number | 81846-19-7 N | 1.00 | infobox |
| Treprostinil | ChEBI | CHEBI:50861 Y | 1.00 | infobox |
| Treprostinil | ChEMBL | ChEMBL1201254 N | 1.00 | infobox |
| Treprostinil | ChemSpider | 5293353 Y | 1.00 | infobox |
| Treprostinil | CompTox Dashboard (EPA) | DTXSID901021654 | 1.00 | infobox |
| Treprostinil | DrugBank | DB00374 Y | 1.00 | infobox |
| Treprostinil | ECHA InfoCard | 100.236.149 | 1.00 | infobox |
| Treprostinil | Elimination half-life | 4 hours | 1.00 | infobox |
| Treprostinil | Excretion | Urine (79% of administered dose is excreted as 4% unchanged drug and 64% as identified metabolites); feces (13%) | 1.00 | infobox |
| Treprostinil | Formula | C23H34O5 | 1.00 | infobox |
| Treprostinil | IUPHAR/BPS | 5820 | 1.00 | infobox |
| Treprostinil | KEGG | D06213 N | 1.00 | infobox |
| Treprostinil | KEGG | D08628 N | 1.00 | infobox |
| Treprostinil | Legal status | US: ℞-only | 1.00 | infobox |
| Treprostinil | Legal status | EU: Rx-only | 1.00 | infobox |
| Treprostinil | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Treprostinil | License data | US DailyMed: Treprostinil | 1.00 | infobox |
| Treprostinil | MedlinePlus | a622038 | 1.00 | infobox |
| Treprostinil | Metabolism | Substantially metabolized by the liver | 1.00 | infobox |
| Treprostinil | Molar mass | 390.520 g·mol−1 | 1.00 | infobox |
| Treprostinil | Pregnancy category | AU: B3 | 1.00 | infobox |
| Treprostinil | PubChem CID | 6918140 | 1.00 | infobox |
| Treprostinil | Routes of administration | Subcutaneous, intravenous, inhalation, by mouth | 1.00 | infobox |
| Treprostinil | Trade names | Remodulin, Orenitram, Tyvaso, others | 1.00 | infobox |
| Treprostinil | UNII | RUM6K67ESG | 1.00 | infobox |
| Treprostinil | is a | vasodilator | 0.90 | text |
The concept neighborhoods around Treprostinil bring nearby vocabulary together. In this analysis, examples include Inhalation, Use and Medical. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Treprostinil, one of the stronger structural bridges in this analysis connects Treprostinil with Adverse effects. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Treprostinil to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications, Research & Art, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Treprostinil · EN edition · Analysis: TopicsToTalkAbout